NEWS

By: Dan Leonard, Executive Director, We Work For Health The decades-long partnership between the federal government, research-focused...

By: Dan Leonard, Executive Director, We Work For Health Kansas is both a driver and a beneficiary of the most sustained period of growth...

By: Tom Kowalski, Co-Chair, We Work For Health Recent efforts to revive the so-called “Most Favored Nation” (MFN) drug pricing policy...

By: Candace DeMatteis, JD MPH, Policy Director, We Work For Health What do North Carolina’s incredible universities have in common, in...

By: Candace DeMatteis, JD MPH, Policy Director, We Work For Health Smart policymaking and American ingenuity have combined to create an...

While the 1980s is best remembered for its questionable fashion and cultural influence, two critical policies from early in the decade...

The FDA approved 55 new drugs in 2023 — up substantially from 2022's 37 approvals, and barely behind the all-time record of 59 set in...

The Biden administration may soon double down on one of its gravest mistakes. In 2022, it supported a petition before the World Trade...

Forty-three years ago, a young U.S. Sen. Joe Biden voted for a transformative policy reform that subsequently catalyzed upwards of $2...

The idea that the government could forcibly seize ownership of a groundbreaking invention you created is chilling. But that is the...

The Biden administration may soon gut the Bayh-Dole Act, one of our nation's most important and impactful laws that also supports nearly...

The inflationary spiral that drove prices up during the first years of the Biden administration has ended. That’s the good news. The bad...